ARTICLE SUMMARY:
Abbott’s recently announced deal to acquire St. Jude Medical for $25 billion underscores just how much the cardiovascular market has changed since CEO Miles White took office in 1998.
The Abbott Laboratories that Miles White inherited when he became CEO in 1998 was a much different Abbott Laboratories than the one he’ll leave when he finally retires.
